Idenix Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference CAMBRIDGE, Mass., Jan. 2, 2013 (GLOBE NEWSWIRE) -- Idenix Pharmaceuticals, Inc. (Nasdaq:IDIX) announced today that Idenix management will present a corporate overview at the 31^st Annual J.P. Morgan Healthcare Conference on January 9, 2013 at 2:00 p.m. PT at the Westin St. Francis in San Francisco. The live and archived webcast of the company presentation can be accessed under "Events and Presentations" in the Idenix Investor Center at www.idenix.com. Please log in approximately 5-10 minutes before the event to ensure a timely connection. The archived replay will be available on the Idenix website for two weeks following the conference. About Idenix Idenix Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases. Idenix's current focus is on the treatment of patients with chronic hepatitis C infection. For further information about Idenix, please refer to http://www.idenix.com. CONTACT: Idenix Pharmaceuticals Contacts: Kelly Barry (617) 995-9033 (media) Teri Dahlman (617) 995-9807 (investors)
Idenix Pharmaceuticals to Present at the 31st Annual J.P. Morgan Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.